E. Nurhayatun, “Oral N-Acetyl cysteine lowered IL 6 level among stage V chronic kidney disease patients on Continuous Ambulatory Peritoneal Dialysis (CAPD)”, JKKI, vol. 8, no. 3, pp. 183–190, Dec. 2017.